منابع مشابه
Posttransplantation maintenance therapy and optimal frontline therapy in myeloma.
One of the major efforts to improve the results of intensive therapy and autologous stem cell transplantation (ASCT) in multiple myeloma involves the integration of novel agents into the transplantation sequence. This can include their administration before, during, and after the transplantation procedure. Several phase 2 and 3 studies have evaluated the use of novel agents as part of induction...
متن کاملAntibiotic Therapy *
The advent of each new antibiotic is not an unmixed blessing. The advantage of acquiring another agent whose range of antibacterial activity parallels that of already existing antibiotics is somewhat offset by the necessity of re-evaluating the known in the light of the new unknown. And involved is not just the effectiveness of one agent versus another, but the relative cost, potential toxicity...
متن کاملFrontline therapy for chronic lymphocytic leukemia: the dilemma continues.
To the Editor: I would like to congratulate Bosch and colleagues on a well-conducted clinical investigation confirming the activity of the FCM (fludarabine, cyclophosphamide, and mitoxantrone) program in previously untreated chronic lymphocytic leukemia (1). Bosch and colleagues reported that FCM provides an overall response rate of 90% with a complete response of 64%. In addition, using a high...
متن کاملFrontline Therapy in Mantle Cell Lymphoma: New Standards in 2017
Introduction Mantle cell lymphoma (MCL) is a B-cell lymphoma characterized by the t(11;14) translocation and cyclin D1 overexpression. MCLs compose 3% to 6% of non-Hodgkin lymphomas, with an annual incidence of 0.5 per 100,000 population in Western countries. MCL has been identified as aggressive, with median survival reaching only 3 to 4 years. However, while most MCL cases fit a pattern of co...
متن کاملCurrent trials for frontline therapy of mantle cell lymphoma
Mantle cell lymphoma (MCL) is a rare and incurable subtype of non-Hodgkin's lymphoma that generally affects older individuals. However, the use of high-dose therapy and autologous stem cell transplant has improved significantly the prognosis of this hematological malignancy, but at the cost of increased toxicities, such as acute toxic death and secondary malignancies. But thanks to a rising und...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Medicine
سال: 2013
ISSN: 1470-2118,1473-4893
DOI: 10.7861/clinmedicine.13-3-263